|
|
||||||||
The Annals of Thoracic Surgery, Vol 37, 229-232, Copyright © 1984 by The Society of Thoracic Surgeons
RC Chiu and R Samson
Anaphylatoxins produced by complement activation have been postulated to be
responsible for postperfusion syndrome and protamine hypotension in
patients undergoing cardiac surgical procedures. The consumption of serum
complement components C3 and C4, which reflects the classic and alternate
pathway activations of the complement system, was studied in 22 patients
undergoing cardiac operations. Prior to the onset of cardiopulmonary
bypass, the complement levels were within normal range. Rapid reduction in
both C3 and C4 within minutes of cardiopulmonary bypass indicated rapid
complement activation. Such a reduction in complement levels could not be
accounted for by either hemodilution or transfusion of complement-poor
blood. Aortic cross-clamping and cold potassium cardioplegia followed by
myocardial reperfusion did not lead to further consumption of C3 and C4.
Slow intravenous infusion of protamine sulfate after cardiopulmonary bypass
did not change C3 and C4 levels significantly in our patients, although
protamine and heparin- protamine complex have been shown to activate
complement components in vitro. In another group of 9 similar cardiac
surgical patients, C3 and C4 were found to return to normal levels within
24 hours after operation. This study thus confirms the rapid activation of
the complement system by cardiopulmonary bypass but fails to demonstrate
further activation of the complement system by cardioplegia or protamine
administration.
ARTICLES
Complement (C3, C4) consumption in cardiopulmonary bypass, cardioplegia, and protamine administration
This article has been cited by other articles:
![]() |
N. Briffa Off pump coronary artery bypass: a passing fad or ready for prime time? Eur. Heart J., June 1, 2008; 29(11): 1346 - 1349. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Sabik, A. M. Gillinov, E. H. Blackstone, C. Vacha, P. L. Houghtaling, J. Navia, N. G. Smedira, P. M. McCarthy, D. M. Cosgrove, and B. W. Lytle Does off-pump coronary surgery reduce morbidity and mortality? J. Thorac. Cardiovasc. Surg., October 1, 2002; 124(4): 698 - 707. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hamulu, B. Discigil, M. Ozbaran, T. Calkavur, E. Kara, A. Kokuludag, S. Buket, and O. Bilkay Complement consumption during cardiopulmonary bypass: comparison of Duraflo II heparin-coated and uncoated circuits in fully heparinized patients Perfusion, January 1, 1996; 11(4): 333 - 337. [Abstract] [PDF] |
||||
![]() |
W.P. Chan, B. Bharadwaj, and K. Prasad Effects of Diltiazem on the Functional Recovery of the Myocardium at Organ and Cellular Level During Prolonged Hypothermic Ischemic Cardiac Arrest Angiology, September 1, 1990; 41(9): 702 - 714. [Abstract] [PDF] |
||||
![]() |
Y. Miyamoto, H. Matsuda, and Y. Kawashima Deleterious Effects of Complement Activation on the Lungs during Extracorporeal Circulation and Its Inhibition by FUT-175 J Biomater Appl, July 1, 1989; 4(1): 56 - 68. [Abstract] |
||||
![]() |
L. L Mickleborough, G. Arnold, and R. C-J Chiu Complement consumption during cardiopulmonary bypass: bubble versus membrane oxygenators Perfusion, October 1, 1986; 1(4): 261 - 269. [Abstract] [PDF] |
||||
![]() |
D. Jones, T. Higenbottam, D. Wheeldon, J. Kneeshaw, and D. Bethune Prostacyclin, cardiopulmonary bypass and the alveolar capillary membrane Perfusion, July 1, 1986; 1(3): 165 - 173. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |